A share price of RenovoRx Inc [RNXT] is currently trading at $1.19, down -4.80%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RNXT shares have gain 28.70% over the last week, with a monthly amount drifted -2.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RenovoRx Inc experienced fluctuations in its stock price throughout the past year between $0.75 and $1.69. RenovoRx Inc [NASDAQ: RNXT] shares were valued at $1.19 at the most recent close of the market.
Analyzing the RNXT fundamentals
Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -16.99%, Pretax Profit Margin comes in at -16.11%, and Net Profit Margin reading is -16.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.78, Equity is -1.21 and Total Capital is -0.93. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1467 points at the first support level, and at 1.1033 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.2467, and for the 2nd resistance point, it is at 1.3033.
Ratios To Look Out For
To put it in perspective, the Current Ratio for RenovoRx Inc [NASDAQ:RNXT] is 8.61. In addition, the Quick Ratio stands at 8.61 and the Cash Ratio stands at 7.91. Considering the valuation of this stock, the price to sales ratio is 66.08, the price to book ratio is 4.10.
Transactions by insiders
Recent insider trading involved Bagai Shaun, Chief Executive Officer, that happened on Aug 22 ’25 when 5000.0 shares were purchased. Chief Executive Officer, Bagai Shaun completed a deal on Aug 25 ’25 to buy 5000.0 shares. Meanwhile, Chief Medical Officer Agah Ramtin bought 21000.0 shares on Jun 05 ’25.
